Steroid Withdrawal Increases Risk of Acute Rejection but Reduces Infection: A Meta-Analysis of 1681 Cases in Renal Transplantation

Transplantation Proceedings

Volumn 38, Issue 7, 2006, Pages 2054-2056

  Tan, J Y ^a,b   Zhao, N ^a   Wu, T X ^a   Yang, K H ^b   Zhang, J D ^b   Tian, J H ^b   Liu, Y L ^b   Wang, K J ^a   Chen, F ^a   Li, S F ^a   Li, Y P ^a  

^a SICHUAN UNIVERSITY   (China)

^b LANZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; BASILIXIMAB; CALCINEURIN INHIBITOR; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ARTICLE; CHRONIC GRAFT REJECTION; CLINICAL TRIAL; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; DRUG SAFETY; DRUG WITHDRAWAL; GRAFT INFECTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTION PREVENTION; KIDNEY TRANSPLANTATION; META ANALYSIS; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; RECIPIENT; RISK BENEFIT ANALYSIS; SEPSIS; SYSTEMATIC REVIEW; URINARY TRACT INFECTION;

ADRENAL CORTEX HORMONES; COMMUNICABLE DISEASE CONTROL; CREATININE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; INFECTION; KIDNEY TRANSPLANTATION; RANDOMIZED CONTROLLED TRIALS; SAFETY; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 33846107877     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.06.039     Document Type: Article

References (12)

1. Hricik D.E., O'Toole M.A., and Schulak J.A. Steroid-free immunosuppression in cyclosporine-treated renal transplant recipients: a meta-analysis. J Am Soc Nephrol 4 (1993) 1300
2. Kasiske B.L., Chakkera H.A., and Louis T.A. A meta-analysis of immunosuppression withdrawal trials in renal transplantation. J Am Soc Nephrol 11 (2000) 1910
3. Pascual J., Quereda C., and Zamora J. Steroid withdrawal in renal transplant patients on triple therapy with a calcineurin inhibitor and mycophenolate mofetil: a meta-analysis of randomized, controlled trials. Transplantation 78 (2004) 1548
4. Ahsan N., Hricik D., and Matas A. Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil a prospective randomized study. Transplantation 68 (1996) 1865
5. Nowacka-Cieciura E., Durlik M., and Cieciura T. Steroid withdrawal after renal transplantation-risks and benefits. Transplant Proc 34 (2002) 560
6. Sola E., Alferez M.J., and Cabello M. Low-dose and rapid steroid withdrawal in renal transplant patients treated with tacrolimus and mycophenolate mofetil. Transplant Proc 34 (2002) 1689
7. Boletis J.N., Konstadinidou I., and Chelioti H. Successful withdrawal of steroid after renal transplantation. Transplant Proc 33 (2001) 1231
8. Laftavi M.R., Stephan R., and Stefanick B. Randomized prospective trial of early steroid withdrawal compared with low-dose steroids in renal transplant recipients using serial protocol biopsies to assess efficacy and safety. Surgery 137 (2005) 364
9. Smak G.P.J., de S.R.G., and Ligtenberg G. Withdrawal of cyclosporine or prednisone six months after kidney transplantation in patients on triple drug therapy: a randomized, prospective, multicenter study. J Am Soc Nephrol 13 (2002) 1365
10. Squifflet J.P., Vanrenterghem Y., and van H.J.P. Safe withdrawal of corticosteroids or mycophenolate mofetil: results of a large, prospective, multicenter, randomized study. Transplant Proc 34 (2002) 1584
11. Vanrenterghem Y., Lebranchu Y., and Hene R. Double-blind comparison of two corticosteroid regimens plus mycophenolate mofetil and cyclosporine for prevention of acute renal allograft rejection. Transplantation 70 (2000) 1352
12. Puig i mari{dotless}́ J.M., and Spanish group of the cellcept study. Induction treatment with mycophenolate mofetil, cyclosporine, and low-dose steroids with subsequent early withdrawal in renal transplant patients: results of the Spanish group. Transplant Proc 31 (1999) 2256